Holen Sie sich die Stockscreener-App
12.18
2.51%
-0.30
Überblick
Nachrichten
Preisverlauf
Optionskette
Financials
Forum
Prognose
Aktiensplit
Dividendenhistorie
Schlusskurs vom Vortag:
$12.48
Offen:
$12.54
24-Stunden-Volumen:
738.54K
Relative Volume:
0.21
Marktkapitalisierung:
$2.43B
Einnahmen:
$3.90B
Nettoeinkommen (Verlust:
$-413.00M
KGV:
-5.8841
EPS:
-2.07
Netto-Cashflow:
$365.00M
1W Leistung:
+7.96%
1M Leistung:
+9.51%
6M Leistung:
-26.57%
1J Leistung:
-35.45%
1-Tages-Spanne:
$12.13
$12.69
1-Wochen-Bereich:
$11.28
$12.69
52-Wochen-Spanne:
$9.85
$20.59
Dentsply Sirona Inc Stock (XRAY) Company Profile
Firmenname
Dentsply Sirona Inc
Sektor
Telefon
844-546-3722
Adresse
13320 BALLANTYNE CORPORATE PLACE, CHARLOTTE, NC
Vergleichen Sie XRAY mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
XRAY
Dentsply Sirona Inc
|
12.17 | 2.49B | 3.90B | -413.00M | 365.00M | -2.07 |
|
ISRG
Intuitive Surgical Inc
|
585.13 | 207.41B | 9.61B | 2.77B | 2.27B | 7.555 |
|
BDX
Becton Dickinson Co
|
201.97 | 58.46B | 21.84B | 1.68B | 2.67B | 5.8293 |
|
ALC
Alcon Inc
|
79.03 | 39.60B | 10.19B | 1.05B | 1.38B | 2.1044 |
|
RMD
Resmed Inc
|
250.66 | 36.63B | 5.26B | 1.44B | 1.76B | 9.7713 |
|
MDLN
Medline Inc
|
41.89 | 32.47B | 27.43B | 1.27B | 1.01B | 1.5829 |
Dentsply Sirona Inc Stock (XRAY) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-12-09 | Eingeleitet | Barclays | Underweight |
| 2025-11-07 | Herabstufung | William Blair | Outperform → Mkt Perform |
| 2025-04-15 | Herabstufung | Morgan Stanley | Overweight → Equal-Weight |
| 2025-03-13 | Herabstufung | Needham | Buy → Hold |
| 2025-02-14 | Eingeleitet | Wells Fargo | Equal Weight |
| 2025-01-23 | Herabstufung | Jefferies | Buy → Hold |
| 2025-01-07 | Herabstufung | Evercore ISI | Outperform → In-line |
| 2024-12-04 | Eingeleitet | Mizuho | Neutral |
| 2024-11-07 | Herabstufung | Leerink Partners | Outperform → Market Perform |
| 2024-10-25 | Bestätigt | Needham | Buy |
| 2024-08-20 | Bestätigt | Needham | Buy |
| 2024-02-26 | Eingeleitet | Leerink Partners | Outperform |
| 2023-11-16 | Eingeleitet | Needham | Buy |
| 2023-11-10 | Hochstufung | William Blair | Mkt Perform → Outperform |
| 2023-01-12 | Hochstufung | William Blair | Underperform → Mkt Perform |
| 2022-08-05 | Herabstufung | William Blair | Mkt Perform → Underperform |
| 2022-06-02 | Hochstufung | UBS | Neutral → Buy |
| 2022-04-20 | Herabstufung | Piper Sandler | Overweight → Neutral |
| 2022-04-20 | Herabstufung | William Blair | Outperform → Mkt Perform |
| 2022-04-19 | Herabstufung | BofA Securities | Buy → Neutral |
| 2022-04-19 | Herabstufung | Robert W. Baird | Outperform → Neutral |
| 2022-01-31 | Eingeleitet | Morgan Stanley | Overweight |
| 2021-10-01 | Fortgesetzt | Credit Suisse | Outperform |
| 2021-08-09 | Bestätigt | H.C. Wainwright | Neutral |
| 2021-08-06 | Bestätigt | Barrington Research | Outperform |
| 2021-08-05 | Fortgesetzt | Credit Suisse | Outperform |
| 2021-03-02 | Hochstufung | Barrington Research | Mkt Perform → Outperform |
| 2021-03-02 | Bestätigt | H.C. Wainwright | Neutral |
| 2021-01-05 | Bestätigt | H.C. Wainwright | Neutral |
| 2020-12-18 | Herabstufung | Stifel | Buy → Hold |
| 2020-11-17 | Herabstufung | Barclays | Equal Weight → Underweight |
| 2020-11-09 | Bestätigt | H.C. Wainwright | Neutral |
| 2020-10-22 | Hochstufung | Guggenheim | Neutral → Buy |
| 2020-08-10 | Bestätigt | H.C. Wainwright | Neutral |
| 2020-06-16 | Eingeleitet | Piper Sandler | Overweight |
| 2020-06-15 | Bestätigt | H.C. Wainwright | Neutral |
| 2020-05-27 | Hochstufung | Evercore ISI | In-line → Outperform |
| 2020-05-11 | Herabstufung | Barrington Research | Outperform → Mkt Perform |
| 2020-04-24 | Bestätigt | H.C. Wainwright | Neutral |
| 2020-04-08 | Hochstufung | Robert W. Baird | Neutral → Outperform |
| 2020-04-07 | Herabstufung | Goldman | Buy → Neutral |
| 2020-04-02 | Hochstufung | Wolfe Research | Peer Perform → Outperform |
| 2020-03-03 | Bestätigt | H.C. Wainwright | Neutral |
| 2020-02-19 | Bestätigt | Stifel | Buy |
| 2019-12-11 | Herabstufung | JP Morgan | Overweight → Neutral |
| 2019-08-02 | Hochstufung | Wellington Shields | Hold → Gradually Accumulate |
| 2019-07-26 | Eingeleitet | Evercore ISI | In-line |
| 2019-07-09 | Bestätigt | H.C. Wainwright | Neutral |
| 2019-05-30 | Eingeleitet | Wolfe Research | Peer Perform |
Alle ansehen
Dentsply Sirona Inc Aktie (XRAY) Neueste Nachrichten
Jim Cramer on DENTSPLY SIRONA: "I Think It Absolutely Represents Some Value Here" - Finviz
How DENTSPLY SIRONA Inc. stock benefits from tech adoption2025 Buyback Activity & Weekly Watchlist for Hot Stocks - ulpravda.ru
A Look At DENTSPLY SIRONA (XRAY) Valuation After Recent Share Price Momentum And Prolonged Weak Returns - Yahoo Finance
Global Dental Equipment Market is expected to generate a revenue of USD 17.68 Billion by 2032, Globally, at 12.35% CAGR: Verified Market Research® - GlobeNewswire Inc.
Published on: 2026-01-08 22:29:20 - ulpravda.ru
Why hedge funds are buying DENTSPLY SIRONA Inc. stock2025 Pullback Review & Smart Investment Allocation Insights - ulpravda.ru
Published on: 2026-01-08 19:44:06 - ulpravda.ru
Jim Cramer on DENTSPLY SIRONA: “I Think It Absolutely Represents Some Value Here” - Insider Monkey
Intraoral Radiography Market is expected to reach US$ 2.7 - openPR.com
Analysts Are Bullish on These Healthcare Stocks: Fortrea Holdings Inc. (FTRE), DENTSPLY SIRONA (XRAY) - The Globe and Mail
Why Dentsply Sirona (XRAY) Stock Is Trading Up Today - Finviz
Bank of America Securities Reaffirms Their Hold Rating on DENTSPLY SIRONA (XRAY) - The Globe and Mail
Dentsply Sirona to Present at 44th Annual J.P. Morgan Healthcare Conference on January 13, 2026 - Quiver Quantitative
Dentsply Sirona to Present at the 44th Annual J.P. Morgan Healthcare Conference - The Manila Times
Dentsply Sirona Stock Up on Analyst RatingMarket Performance & Outlook | Jan 2026News and Statistics - IndexBox
The Truth About Dentsply Sirona Inc: Why Wall Street Is Watching While TikTok Sleeps On It - AD HOC NEWS
XRAY: Analyst Ratings and Target Price Unchanged by Barrington R - GuruFocus
DENTSPLY SIRONA's (XRAY) "Outperform" Rating Reiterated at Barrington Research - MarketBeat
Titanium & Titanium Alloys Dental Implants Market is expected - openPR.com
DENTSPLY SIRONA Inc Stock Analysis and ForecastEarnings Surprise Analysis & Build Your Portfolio With Our Free Stock Scanner - earlytimes.in
Dental Resin Market 2025-2032: Key Trends, Opportunities, - openPR.com
Dental Implants Market Booming with Rapid Growth Through 2032 | - openPR.com
Dental Digital X-ray Market Set to Transform Oral Care: - openPR.com
Dentsply Sirona Amends Credit Facilities to Enhance Flexibility - TipRanks
Dentsply Sirona amends credit agreements and updates debt covenants By Investing.com - Investing.com Nigeria
Dentsply Sirona amends credit agreements and updates debt covenants - Investing.com
Dentsply Sirona Updates Multiple Financing Agreements With Major Lenders - TradingView — Track All Markets
Why Is DENTSPLY SIRONA Inc. (DY2.DE) Stock Up Today? - Meyka
DENTSPLY SIRONA Inc. $XRAY Shares Purchased by Cwm LLC - MarketBeat
The Truth About Dentsply Sirona Inc: Is This ‘Boring’ Dental Stock a Secret Money Play? - AD HOC NEWS
Japan Dental Equipment Market is expected to reach US$ 9.20 - openPR.com
Dentsply Sirona stock holds $11.5 in early premarket as dividend date passes and earnings come into view - ts2.tech
Dentsply Sirona Earnings Notes - Trefis
Specialty Medical Chairs Market Analysis 2025 Review - openPR.com
Dentsply Sirona Stock (NASDAQ: XRAY) Update: Analysts’ “Reduce” Consensus, Dividend Timeline, and Key Catalysts Before Monday’s Open - ts2.tech
DENTSPLY SIRONA Stock (NASDAQ: XRAY) Weekend Update: Analysts Hold a “Reduce” View as Year-End Trading Winds Down - ts2.tech
Dentsply Sirona (XRAY) Stock Weekend Update: Dividend, Turnaround Plan, Analyst Targets—and What to Watch When Nasdaq Reopens - ts2.tech
Here’s What Weakened DENTSPLY SIRONA (XRAY) Shares - MSN
DENTSPLY SIRONA Inc. (NASDAQ:XRAY) Receives Consensus Rating of "Reduce" from Analysts - MarketBeat
DENTSPLY SIRONA Inc. (NASDAQ:XRAY) Receives Average Recommendation of "Reduce" from Brokerages - MarketBeat
DENTSPLY SIRONA Inc.: - marketscreener.com
Dental Equipment & Technology Stocks Q3 Results: Benchmarking Dentsply Sirona (NASDAQ:XRAY) - Yahoo Finance
Ex-Dividend Reminder: Medtronic, Danaher and DENTSPLY SIRONA - Nasdaq
Endodontics Market Size, Share & Forecast 2026–2035 - Global Market Insights Inc.
DENTSPLY SIRONA Inc. (XRAY) Investor Outlook: Exploring a 13.38% Upside Potential Amidst Challenging Metrics - DirectorsTalk Interviews
Bio-implant Market Projected to Witness Huge Growth - openPR.com
Sound Income Strategies LLC Boosts Stock Holdings in DENTSPLY SIRONA Inc. $XRAY - MarketBeat
Analysts Offer Insights on Healthcare Companies: Novavax (NVAX) and DENTSPLY SIRONA (XRAY) - The Globe and Mail
Dentsply Sirona declares $0.16 dividend - MSN
Why DENTSPLY SIRONA Inc. (DY2) stock signals breakout potentialWeekly Trend Recap & Daily Profit Maximizing Tips - Улправда
Can Dentsply Sirona Stock Hold Up When Markets Turn? - Trefis
Finanzdaten der Dentsply Sirona Inc-Aktie (XRAY)
Umsatz
Nettogewinn
Free Cashflow
ENV
Dentsply Sirona Inc-Aktie (XRAY) Insiderhandel
| Insiderhandel | Beziehung | Datum | Transaktion | Kosten | #Aktien | Wert ($) | #Aktien Gesamt |
|---|---|---|---|---|---|---|---|
| LUCIER GREGORY T | Director |
Dec 08 '25 |
Sale |
11.14 |
82,200 |
915,708 |
0 |
| VARON LESLIE F | Director |
Nov 24 '25 |
Buy |
10.71 |
9,337 |
99,999 |
57,343 |
| LUCIER GREGORY T | Director |
Mar 03 '25 |
Buy |
16.51 |
15,142 |
249,994 |
81,971 |
0.83%
0.65%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):